Related Experiment Video
Updated: Jul 5, 2026

Protein Target Prediction and Validation of Small Molecule Compound
Published on: February 23, 2024
Direct AKAP-mediated protein-protein interactions as potential drug targets
1Leibniz-Institut für Molekulare Pharmakologie, Robert-Rössle-Str. 10, Berlin, Germany.
A-kinase-anchoring proteins (AKAPs) are crucial scaffolding proteins that organize cellular signaling. Disrupting AKAP interactions offers potential for novel cardiovascular and renal disorder treatments.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Biochemistry
Background:
- A-kinase-anchoring proteins (AKAPs) are a family of scaffolding proteins.
- They bind protein kinase A (PKA) and other signaling molecules, forming localized signaling modules.
- AKAPs are essential for integrating and compartmentalizing cellular processes.
Purpose of the Study:
- To review AKAP functions, focusing on disruption of AKAP-mediated protein-protein interactions.
- To highlight the therapeutic potential of targeting AKAP interactions for disease treatment.
Main Methods:
- Gene targeting and knockdown approaches to study AKAP function.
- Pharmacological disruption of AKAP-dependent protein-protein interactions using peptides.
- Review of existing literature on AKAP roles in physiological processes.
Main Results:
- AKAPs regulate critical cellular functions, including cardiac contractility and kidney water reabsorption.
- Disruption of AKAP function is linked to cardiovascular and renal disorders.
- Peptide-mediated disruption of AKAP interactions reveals their significance.
Conclusions:
- AKAP-mediated protein-protein interactions are key targets for novel drug development.
- Targeting AKAPs offers a promising strategy for treating cardiovascular and renal diseases.
- Understanding AKAP signaling is vital for advancing therapeutic interventions.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein-protein Interfaces
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...